Data on longitudinal changes in LF mf infection prevalences, and on MDA interventions carried out in six representative low, medium and high transmission sites (DokanTofa, Nigeria; Piapung, Nigeria; Mossasso, Mali; Kirare, Tanzania; Peneng, Papua New Guinea (PNG); Dozanso, Mali), were assembled from the published literature39–43 for use in calibrating and running simulations of the EPIFIL model in this study. The six sites were selected on the basis of providing data on the level of baseline mf prevalence, where DokanTofa and Piapung represent low-prevalence sites (mf prevalence 1–15%), Mossasso and Kirare embody medium-prevalence sites (mf prevalence 16–35%), and Peneng and Dozanso, high-prevalence sites (mf prevalence >35%), respectively, while also giving details on the required inputs for identifying the local LF models applicable to each individual site. These data inputs comprise information on the annual biting rate (ABR) and dominant mosquito genus, as well as MDA intervention details, including the relevant drug regimen used, frequency, and population coverages of the applied MDAs (Supplementary Table 2).
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.